232 followers
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. https://t.co/8PcixJt1qP
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial. https://t.co/8PcixJt1qP
Great to see this publication of a protocol we are supporting here in Sheffield CRF. Why not have a read and find out more about OPTION DM?
RT @OPTION_DM: Our protocol has been published in @BioMedCentral. Read it here: https://t.co/hyvPJLljjz
Our protocol has been published in @BioMedCentral. Read it here: https://t.co/hyvPJLljjz